Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  I 131 monoclonal antibody CC49
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-11 of 11 for your search:
Start Over
Phase II Study of IFN-A-Enhanced, Single-Dose 131I-MOAB CC49 for Metastatic Hormone-Resistant Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAC-2153, NCI-B93-0013, B93-0013
Phase II Study of 131I-Labeled MOAB CC-49 Plus IFN-G for Hormone-Refractory Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-93076A1, NCI-T94-0042C, T94-0042
Phase II Study of 131I-Labeled MOAB CC-49 in Patients with Advanced Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-91022, NCI-T91-0216C, T91-0216
Phase II Study of 131I-Labeled Anti-TAG-72 MOAB CC-49 in Patients with Hormone-Resistant Metastatic Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAC-2112, NCI-T91-0218C, T91-0218
Phase II Study of 131I-Labeled Anti-TAG-72 Monoclonal Antibody (MOAB CC-49) Enhanced with IFN-A in Patients with Refractory Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAC-2131, NCI-T92-0169C, T92-0169
Phase II Study of IFN-A Enhanced 131I-Labeled MOAB CC-49 and MOAB COL-1 in Patients with Metastatic Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor:
Protocol IDs: UAC-2152, NCI-B93-0012, B93-0012
Phase I Study of 131I-Labeled Monoclonal Antibody CC-49 Followed by Total-Body Irradiation and Thiotepa with Autologous Peripheral Blood Stem Cell Rescue for Metastatic Breast Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to physiologic 65
Sponsor: NCI
Protocol IDs: UAB-9505, NCI-B95-0005, B95-0005
Phase I Study of 131I-Radiolabeled MOAB CC-49 in Patients with Metastatic or Unresectable Gastrointestinal Adenocarcinoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 19 to 65
Sponsor: NCI
Protocol IDs: UNMC-28191, NCI-T91-0159O, T91-0159
Phase I Pilot Study of Intravenous 131I-CC49 Monoclonal Antibody with Deoxyspergualin Immunomodulation in Patients with Advanced Colorectal Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-93029, NCI-B92-0002, B92-0002
Phase I Study of 131I-Labeled MOAB CC49 and Total Body Irradiation with Autologous Stem Cell Rescue Following Induction With High-Dose CTX for Hormone-Resistant Metastatic Prostate Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to physiologic 60
Sponsor: NCI
Protocol IDs: UAC-1151, NCI-B93-0011, B93-0011
Start Over